109 related articles for article (PubMed ID: 2775623)
1. Plasma protein binding of frusemide in liver disease: effect of hypoalbuminaemia and hyperbilirubinaemia.
Viani A; Carrai M; Pacifici GM
Br J Clin Pharmacol; 1989 Aug; 28(2):175-8. PubMed ID: 2775623
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects.
Viani A; Pacifici GM
Dev Pharmacol Ther; 1989; 14(2):90-5. PubMed ID: 2630237
[TBL] [Abstract][Full Text] [Related]
3. The effect of hypoalbuminaemia, hyperbilirubinaemia and renal failure on serum fructosamine concentration in non-diabetic individuals.
Dominiczak MH; Orrell JM; Finlay WE
Clin Chim Acta; 1989 Jun; 182(2):123-9. PubMed ID: 2776348
[TBL] [Abstract][Full Text] [Related]
4. Quantitative contribution of endogenous compounds and hypoalbuminemia in reducing the binding of furosemide in the plasma of newborn infants.
Viani A; Pacifici GM
Dev Pharmacol Ther; 1992; 18(1-2):39-43. PubMed ID: 1483361
[TBL] [Abstract][Full Text] [Related]
5. Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
Goto S; Yoshitomi H; Miyamoto A; Yamada H; Fujii S; Nakayama T; Fujiwara K
J Pharmacobiodyn; 1981 Nov; 4(11):865-73. PubMed ID: 7328487
[TBL] [Abstract][Full Text] [Related]
6. Plasma protein binding of furosemide in the elderly.
Pacifici GM; Viani A; Schulz HU; Frercks HJ
Eur J Clin Pharmacol; 1987; 32(2):199-202. PubMed ID: 3582485
[TBL] [Abstract][Full Text] [Related]
7. Nimesulide binding to components within blood.
Bree F; Nguyen P; Urien S; Albengres E; Macciocchi A; Tillement JP
Drugs; 1993; 46 Suppl 1():83-90. PubMed ID: 7506199
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of frusemide are influenced by age.
Andreasen F; Hansen U; Husted SE; Jansen JA
Br J Clin Pharmacol; 1983 Oct; 16(4):391-7. PubMed ID: 6626433
[TBL] [Abstract][Full Text] [Related]
9. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
Viani A; Rizzo G; Carrai M; Pacifici GM
Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
[TBL] [Abstract][Full Text] [Related]
10. Frusemide pharmacokinetics in patients with liver disease.
Allgulander C; Beermann B; Sjögren A
Clin Pharmacokinet; 1980; 5(6):570-5. PubMed ID: 7438654
[TBL] [Abstract][Full Text] [Related]
11. Furosemide binding to human albumin and plasma of nephrotic children.
Prandota J; Pruitt AW
Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
[TBL] [Abstract][Full Text] [Related]
12. Diseases and drug protein binding.
Tillement JP; Lhoste F; Giudicelli JF
Clin Pharmacokinet; 1978; 3(2):144-54. PubMed ID: 25156
[TBL] [Abstract][Full Text] [Related]
13. Plasma protein binding of azapropazone in patients with kidney and liver disease.
Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein binding of frusemide in renal failure rabbits: investigation of endogenous protein binding inhibitors.
Ikeda K; Yoshitomi H; Nakayama T; Goto S; Kimura T
J Pharm Pharmacol; 1984 Oct; 36(10):663-7. PubMed ID: 6150082
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis.
Pacifici GM; Viani A; Rizzo G; Carrai M; Rane A
Ther Drug Monit; 1987 Dec; 9(4):369-73. PubMed ID: 3424402
[TBL] [Abstract][Full Text] [Related]
16. Decreased binding of verapamil to plasma proteins in patients with liver disease.
Giacomini KM; Massoud N; Wong FM; Giacomini JC
J Cardiovasc Pharmacol; 1984; 6(5):924-8. PubMed ID: 6209501
[TBL] [Abstract][Full Text] [Related]
17. Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs.
Pacifici GM; Viani A; Rizzo G; Carrai M
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):362-5. PubMed ID: 2777426
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
Powell LW; Axelsen E
Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
[TBL] [Abstract][Full Text] [Related]
19. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
Br J Clin Pharmacol; 1995 Jun; 39(6):692-5. PubMed ID: 7654491
[TBL] [Abstract][Full Text] [Related]
20. Changes in protein binding during disease.
Craig WA; Suh B
Scand J Infect Dis Suppl; 1978; (14):239-44. PubMed ID: 279978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
